United Airlines to offer Abbott’s rapid COVID-19 tests on certain flights; Moderna prepares global launch of potential coronavirus vaccine; Children comprise 11% of U.S. coronavirus cases.
Five things for pharma marketers to know: Thursday, October 29, 2020
Sanofi, GSK give 200 million COVID-19 vaccine doses to Covax; Pfizer will not report coronavirus vaccine results this month; Podcast: Genentech’s Quita Highsmith.
Five things for pharma marketers to know: Wednesday, October 28, 2020
Lilly’s antibody treatment ineffective on patients hospitalized with advanced COVID; Study: Nurses at high risk of contracting coronavirus; CDC to launch V-SAFE to monitor real-time health developments after COVID vaccine distribution.
Fishawack research: COVID has accelerated the pace of industry innovation and change
UnitedHealthcare to provide 200,000 kits including Tamiflu to at-risk patients; AstraZeneca, Oxford COVID-19 vaccine produces similar immune response in older and younger adults; Many pharmacies not giving flu vaccine to children three and younger.
Five things for pharma marketers to know: Monday, October 26, 2020
Final stage for Moderna’s COVID vaccine trial is fully enrolled; 29 out of 40 drugs used to treat coronavirus are in short supply; MM+M Media Summit is Nov. 12.
